88 results on '"Arikian A"'
Search Results
2. PCR138 Association of SARS-CoV-2 Omicron Ba.1 on Adherence to Oral Tetrabenazine Congener and Quality of Life of Patients Diagnosed With Huntington's Disease With Chorea or Tardive Dyskinesia on the Service of a USA Specialty Pharmacy
3. (85) Glasgow Coma Scale scores and Impact of delirium on intubated seizure patients treated with Phenytoin and Lacosamide
4. Delirium During Intubation in Traumatic Brain Injury (TBI) Compared to Non-TBI Patients in Neuro Critical Care
5. POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients
6. PCN208 Association of Quality of Life with Oncology Medication Adherence in Cancer Patients on the Service of a Specialty Pharmacy
7. PDG66 QUALITY OF LIFE AND ADHERENCE OF PATIENTS TO ORAL NEUROLOGY SPECIALTY MEDICATIONS PROVIDED BY A SPECIALTY PHARMACY
8. Comparing real-world evidence among patients with metastatic pancreatic ductal adenocarcinoma treated with liposomal irinotecan
9. Adherence of patients to oral oncolytic and neurologic specialty medications provided by a specialty pharmacy
10. Guiding Diabetic Therapy for Children and Adolescents with Type I Diabetes
11. PMU78 - MEDICATION THERAPY MANAGEMENT WITH DIRECT PATIENT ENGAGEMENT TO ADDRESS NON-ADHERENCE TO SPECIALTY DRUGS
12. Effect of patient- and drug-specific barcode technology on medication dispensing errors in a specialty pharmacy
13. Adherence Of Outpatient Cancer Patients To Oral Oncolytic Medications Provided By A Specialty Pharmacy
14. Real World Data Hub-A Roadmap for Comprehensive Data Strategy and Evidence Development November 17, 2017
15. Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa
16. Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes
17. Patient Counseling By A Specialty Pharmacist Increases Pain Medication Adherence And Persistency
18. Patterns of total cost for patients (pts) with active treatment (Tx) of myelodysplastic syndromes (MDS).
19. Relationship Between Lenalidomide Dose Modification and Outcomes in Patients with Myelodysplastic Syndromes
20. Patterns of Total Costs of Care over Time for Patients with Multiple Myeloma (MM)
21. Patterns of Growth Factor Costs in Multiple Myeloma Patients Treated With Lenalidomide or Bortezomib
22. Lenalidomide Dose Modifications and Associated Patient Outcomes in Newly Diagnosed Multiple Myeloma (NDMM)
23. Patterns of total cost and economic consequences of progression for patients with newly diagnosed multiple myeloma
24. Relationship Between Lenalidomide Dose Modification and Time to Next Treatment in Newly Diagnosed Multiple Myeloma Patients
25. Patterns of Total Costs of Care for Newly Diagnosed Multiple Myeloma (MM) Patients
26. Chilblains in Southern California: two case reports and a review of the literature
27. Body dissatisfaction from adolescence to young adulthood: Findings from a 10-year longitudinal study
28. PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of Hypertension
29. Healthful Eating and Physical Activity in the Home Environment: Results from Multifamily Focus Groups
30. Cognitive-behavioral therapy for subthreshold bulimia nervosa: A case series
31. Cognitive-behavioural group therapy versus guided self-help for compulsive buying disorder: A preliminary study
32. EV3 A COMPARATIVE EFFECTIVENESS INDEX TO INFORM CLINICAL DECISIONS
33. Establishing thresholds for unusually large binge eating episodes
34. Targeting parents for the treatment of pediatric obesity in boys with Duchenne muscular dystrophy: A case series
35. PCV159 COMPARATIVE EFFECTIVENESS INDEX: A CONCEPTUAL APPROACH TO COMPARATIVE EFFECTIVENESS RESEARCH
36. Spatial impacts of soil disturbance and residual overstory on density and growth of regenerating aspen
37. Parental Psychopathology as a Predictor of Long-Term Outcome in Bulimia Nervosa Patients
38. Benefits of Telephone Care Over Primary Care for Smoking Cessation
39. Assessing the Institutional Approach to Implementing Smoking Cessation Practice Guidelines in Veterans Health Administration Facilities
40. Results of a Randomized Controlled Trial of Intervention to Implement Smoking Guidelines in Veterans Affairs Medical Centers
41. A Pharmacoeconomic Evaluation of Seven-Valent Pneumococcal Conjugate Vaccine in Spain
42. Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes
43. A Pharmacoeconomic Evaluation of 7‐Valent Pneumococcal Conjugate Vaccine in Canada
44. A pharmacoeconomic evaluation of results from the coronary angioplasty amlodipine restenosis study (CAPARES) in Norway and Canada
45. A COST‐EFFECTIVENESS EVALUATION OF AMLODIPINE USAGE IN PATIENTS WITH CORONARY ARTERY DISEASE IN SWEDEN
46. PCV16: COST-EFFECTIVENESS OF AMLODIPINE TREATMENT IN PATIENTS WITH CORONARY ARTERY DISEASE IN THE U.K
47. A Review of the Diagnosis, Pharmacologic Treatment, and Economic Aspects of Anxiety Disorders
48. THE HEALTH ECONOMIC IMPACT OF ANTIDEPRESSANT USAGE FROM A PAYER'S PERSPECTIVE: A MULTINATIONAL STUDY
49. THE COST‐EFFECTIVENESS OF DOXAZOSIN FOR THE TREATMENT OF HYPERTENSION IN TYPE II DIABETIC PATIENTS IN THE UK AND ITALY
50. A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.